Researchers are excited about this new drug, a groundbreaking dual compound showing promising results in initial trials for size reduction . It works by modulating both systems: GLP-1 and GIP, which , when stimulated, assist influence cravings and boost metabolism . Preliminary findings suggest considerable body loss and likely benefits for patient